IP Library Assignment 048251/0334
Patent Assignment
Reel/Frame 048251/0334

Assignment of Assignor's Interest

Recorded: 2019-02-06 Pages: 3
Assignors
ABDEL-MEGUID, SHERIN SALAHELDIN
Executed: 2018-12-31
ELSHOURBAGY, NABIL A.
Executed: 2019-01-14
MEYERS, HAROLD V.
Executed: 2019-01-07
MOUSA, SHAKER A.
Executed: 2019-01-18
Assignee
SHIFA BIOMEDICAL CORPORATION
ONE GREAT VALLEY PARKWAY, SUITE 8, MALVERN, PENNSYLVANIA, 19355
Covered Property (1)
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases
Application: 16/308,648 →
Publication: US 2019/0270729
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Jan 25, 2024
From: SHIFA BIOMEDICAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066371/0062 →